SCHEMBL14833338

SCHEMBL14833338

O=C(Cc1ccccc1)n1ccnn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.47
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
AKR1B1 P15121 1/20 0.44
ALDH1A1 P00352 4/20 0.43
BCHE P06276 2/20 0.41
ACHE P22303 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GLA P06280 1/20 0.41
HPGD P15428 1/20 0.41
HSD11B1 P28845 1/20 0.41
KDM4E B2RXH2 2/20 0.40
KMT2A Q03164 2/20 0.40
F2 P00734 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CYP1A1 P04798 1/20 0.39
MEN1 O00255 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
F12 P00748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2518509 0.77 PDE4B (0.48) CES2CES1AKR1B1ALDH1A1BCHE
SCHEMBL29447697 0.76 CYP19A1 (0.39) CYP19A1CES2CES1AKR1B1
SCHEMBL24937837 0.73 NPC1 (0.49) ALDH1A1HPGDKMT2AMEN1
SCHEMBL8508057 0.73 P2RX4 (0.51) ALDH1A1BCHEHPGDKMT2ANPSR1
SCHEMBL21816275 0.73 F2 (0.46) CYP19A1ALDH1A1L3MBTL1HPGDKDM4E
SCHEMBL28698664 0.72 MAPK1 (0.45) CYP19A1CES2CES1AKR1B1ALDH1A1
SCHEMBL17825839 0.72 MEN1 (0.49) CYP19A1ALDH1A1L3MBTL1GLAHPGD
Bicarbonate SCHEMBL15511343 0.71 F2 (0.45) CYP19A1ALDH1A1L3MBTL1HPGDKDM4E
SCHEMBL14693589 0.70 F2 (0.55) ALDH1A1HPGDKDM4EKMT2AF2
SCHEMBL6126592 0.70 CES1 (0.54) CES2CES1AKR1B1ALDH1A1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013049591-A2 DUAL INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF VERSEON CORPORATION (US) 2013-04-04 WO disclosed